PSAT1 prompted cell proliferation and inhibited cell apoptosis in multiple myeloma through regulating PI3K/AKT pathway

被引:4
|
作者
Zhu, Hongqing [1 ,2 ]
Si, Yejun [2 ]
Zhuang, Yun [2 ]
Li, Meng [2 ]
Ji, Jianmin [3 ]
Ji, Ou [2 ,3 ]
Shen, Qun [2 ,3 ]
机构
[1] Nanjing Univ Chinese Med, Dept Hematol, Taizhou Hosp, Taizhou City 225300, Jiangsu, Peoples R China
[2] Nanjing Univ Chinese Med, Nanjing 210046, Jiangsu, Peoples R China
[3] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Hematol, Nanjing 210029, Jiangsu, Peoples R China
关键词
Multiple myeloma; PSAT1; Cell proliferation; P13K/AKT pathway; CANCER CELLS;
D O I
10.4314/tjpr.v19i4.10
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To identify the biological function of phosphoserine aminotransferase 1 (PSAT1) in regulating cell proliferation and apoptosis in multiple myeloma (MM). Methods: The mRNA and protein levels of PSATI were determined using quantitative real-time polymerase chain reaction (PCR) and western blotting, respectively. Cell proliferation was measured using CCK-8 assay. Results: PSAT1 mRNA and protein expression levels were significantly increased in MM cell lines when compared to control cells. Moreover, downregulation of PSAT1 inhibited MM cell proliferation and induced cell apoptosis, whereas overexpression of PSAT1 promoted MM cell proliferation and suppressed cell apoptosis. Further analysis demonstrated that the underlying mechanism was via regulation of PI3K/AKT pathway. Conclusion: The results identified a novel role for PSAT1 in the progression of MM, which may provide a therapeutic and a new anticancer target for the therapy of MM.
引用
收藏
页码:745 / 749
页数:5
相关论文
共 50 条
  • [1] PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway
    Duan, Wenxu
    Liu, Xiaomei
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2020, 50 (04): : 512 - 518
  • [2] NEAT1 promotes cell proliferation in multiple myeloma by activating PI3K/AKT pathway
    Xu, H.
    Li, J.
    Zhou, Z. -G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (19) : 6403 - 6411
  • [3] Plumbagin inhibits cell proliferation and promotes apoptosis in multiple myeloma cells through inhibition of the PI3K/Akt-mTOR pathway
    Wu, Hongwei
    Dai, Xiaozhen
    Wang, Enren
    ONCOLOGY LETTERS, 2016, 12 (05) : 3614 - 3618
  • [4] FoxM1 Regulates Proliferation and Apoptosis of Human Neuroblastoma Cell through PI3K/AKT Pathway
    Liao, Junzuo
    Jiang, Lin
    Wang, Cheng
    Zhao, Dan
    He, Wenfei
    Zhou, Kejun
    Liang, Yun
    FETAL AND PEDIATRIC PATHOLOGY, 2022, 41 (03) : 355 - 370
  • [5] Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway
    Feng, Nan
    Luo, Jianmin
    Guo, Ximin
    MOLECULAR MEDICINE REPORTS, 2016, 13 (04) : 3243 - 3248
  • [6] The role of PI3K/AKT pathway in cell proliferation and apoptosis in oral Squamous Cell Carcinoma
    Ribeiro-Silva, A.
    Duarte, A.
    Silveira, G.
    VIRCHOWS ARCHIV, 2016, 469 : S116 - S116
  • [7] Inhibitor of growth 3 induces cell death by regulating cell proliferation, apoptosis and cell cycle arrest by blocking the PI3K/AKT pathway
    Zhao, Song
    Wang, Long
    Zhang, Chunmei
    Deng, Yu
    Zhao, Bai
    Ren, Yuxin
    Fu, Yingmei
    Meng, Xianzhi
    CANCER GENE THERAPY, 2018, 25 (9-10) : 240 - 247
  • [8] Inhibitor of growth 3 induces cell death by regulating cell proliferation, apoptosis and cell cycle arrest by blocking the PI3K/AKT pathway
    Song Zhao
    Long Wang
    Chunmei Zhang
    Yu Deng
    Bai Zhao
    Yuxin Ren
    Yingmei Fu
    Xianzhi Meng
    Cancer Gene Therapy, 2018, 25 : 240 - 247
  • [9] Naringin inhibits thyroid cancer cell proliferation and induces cell apoptosis through repressing PI3K/AKT pathway
    Zhou, Jun
    Xia, Liang
    Zhang, Yu
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (12)
  • [10] Downregulation of SDCBP inhibits cell proliferation and induces apoptosis by regulating PI3K/AKT/mTOR pathway in gastric carcinoma
    Qian, Bo
    Yao, Zhiheng
    Yang, Yang
    Li, Na
    Wang, Qiao
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2022, 69 (01) : 240 - 247